Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × ravulizumab × 30 days × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Surveys and Questionnaires 19 Blood Specimen Collection 19 Specimen Handling 10 Radiotherapy 9 Immune Checkpoint Inhibitors 8 Watchful Waiting 7 Interviews as Topic 6 Biopsy 6 Observation 5 Drug Therapy 5 ribociclib 4 pembrolizumab 3 lenvatinib 3 enzalutamide 3 Tissue Banks 3 Standard of Care 3 Magnetic Resonance Spectroscopy 3 Liquid Biopsy 3 Letrozole 3 Anastrozole 3 trametinib 2 regorafenib 2 pertuzumab 2 durvalumab 2 darolutamide 2 dabrafenib 2 atezolizumab 2 apalutamide 2 Tomography, X-Ray Computed 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06909253 2026-03-13

MG-ARCADIA

AstraZeneca

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡